Template:STEMI: Difference between revisions

Latest revision as of 11:54, 1 May 2009

v t e ST Elevation Myocardial Infarction
Background	Overview • Epidemiology and Demographics • Classification
Risk factors and Triggers	Risk Factors • Triggers
Pathophysiology	Pathophysiology of Vessel Occlusion • Pathophysiology of Reperfusion• Gross Pathology • Histopathology
Diagnosis	Diagnosis • Symptoms • Differential Diagnosis of Chest Pain • Physical Examination • Electrocardiogram • Right ventricular myocardial infarction • Atrial Infarction • Cardiac Markers • Coronary Angiography
Treatment	Pre-Hospital Care Pre-Hospital Care Initial Care Initial Care • Oxygen • Nitrates • Analgesics • Aspirin • Beta Blockers Pharmacologic Reperfusion • Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) • Fibrinolysis Mechanical Reperfusion • The Importance of Reducing Door-to-Balloon Times • Primary PCI • Adjunctive and Rescue PCI • Rescue PCI • Facilitated PCI • Adjunctive PCI • CABG • Management of Patients Who Were Not Reperfused • Assessing Success of Reperfusion Antithrombin Therapy • Antithrombin therapy • Unfractionated heparin • Low Molecular Weight Heparinoid Therapy • Direct Thrombin Inhibitor Therapy • Factor Xa Inhibition Antiplatelet Agents • Aspirin • Thienopyridine Therapy • Glycoprotein IIbIIIa Inhibition Inhibition of the Renin-Angiotensin-Aldosterone System • Inhibition of the Renin-Angiotensin-Aldosterone System Other Adjunctive Therapies • Magnesium Therapy • Glucose Control • Calcium Channel Blocker Therapy
Monitoring	Arrhythmia Monitoring
Complications	Complications
Discharge Care	Secondary Prevention • Cardiac Rehabilitation • Prognosis

Retrieved from "https://www.wikidoc.org/index.php?title=Template:STEMI&oldid=542763"

Categories:

@@ Line 29: / Line 29: @@
 [[ST Elevation Myocardial Infarction Coronary Artery Bypass Grafting|CABG]] • [[ST Elevation Myocardial Infarction Management of Patients Who Were Not Reperfused|Management of Patients Who Were Not Reperfused]] • [[ST Elevation Myocardial Infarction Assessing Success of Reperfusion|Assessing Success of Reperfusion]]
-'''Antithrombin Therapy'''  • [[ST elevation myocardial infarction antithrombin therapy|Antithrombin therapy]] • [[ST elevation myocardial infarction antithrombin therapy#Unfractionated Heparin|Unfractionated heparin]]  • [[ST elevation myocardial infarction antithrombin therapy#Low Molecular Weight Heparinoids| Low Molecular Weight Heparinoid Therapy]] • [[ST elevation myocardial infarction antithrombin therapy#Direct Thrombin Inhibitors (DTIs) | Direct Thrombin Inhibitor Therapy]] •  [[ ST elevation myocardial infarction antithrombin therapy#Factor Xa Inhibition|Factor Xa Inhibition]]
+'''Antithrombin Therapy'''  • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy|Antithrombin therapy]] • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Unfractionated Heparin|Unfractionated heparin]]  • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Enoxaparin| Low Molecular Weight Heparinoid Therapy]] • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Bivalirudin | Direct Thrombin Inhibitor Therapy]] •  [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Fondaparinux|Factor Xa Inhibition]]
 '''Antiplatelet Agents''' •  [[ST Elevation Myocardial Infarction Aspirin Therapy|Aspirin]] • [[ST Elevation Myocardial Infarction Thienopyridine Therapy|Thienopyridine Therapy]] • [[ST Elevation Myocardial Infarction Glycoprotein IIbIIIa Inhibition|Glycoprotein IIbIIIa Inhibition]]

Template:STEMI: Difference between revisions

Latest revision as of 11:54, 1 May 2009

Navigation menu